Skip to main content
. 2021 Mar 6;21:235. doi: 10.1186/s12885-021-07962-x

Table 2.

Comparison of clinicopathological features between the PD and the MD groups

PD group MD group p-value
n 409 (%) 50 (%)
Age (years)
Mean ± SD (range) 72.1 ± 8.6 (45–91) 69.7 ± 10.0 (38–86) 0.136
Sex
 Male 313 (76.5%) 38 (76.0%) 0.934
 Female 96 (23.5%) 12 (24.0%)
Main component
 Well differentiated 331 (80.9) 17 (34.0) < 0.01
 Moderately differentiated 67 (16.4) 30 (60.0)
 Papillary 11 (2.7) 3 (6.0)
Location
 Upper third 89 (21.8) 14 (28.0) 0.251
 Middle third 139 (34.0) 18 (36.0)
 Lower third 181 (44.2) 18 (36.0)
Macroscpic type
 Elevated (I,IIa) 131 (32.0) 15 (30.0) 0.388
 Flat (IIb) 3 (0.7) 1 (2.0)
 Depressed (IIc, III) 232 (56.7) 24 (48.0)
 Complex (elevated+depressed) 43 (10.5) 10 (20.0)
Tumor size (mm)
 Mean ± SD (range) 20.1 ± 15.1 (1–99) 37.3 ± 25.8 (4–128) < 0.01
Depth
 Mucosa 313 (76.5) 17 (34.0) < 0.01
 Submucosa, < 500 μm 48 (11.7) 11 (22.0)
 Submucosa, ≥500 μm 48 (11.7) 22 (44.0)
Lymphatic invasion 21 (5.1) 14 (28.0) < 0.01
Vascular invasion 15 (3.7) 9 (18.0) < 0.01
Ulceration 53 (13.0) 13 (26.0) < 0.01
First treatment
 ESD 369 (90.2) 27 (54.0) < 0.01
 Gastrectomy 40 (9.8) 23 (46.0)
Non-curative resection (for ESD) 46 (12.5) 15 (55.6) < 0.01
LNM 6 (1.5) 5 (10.0) < 0.01

Abbreviations: PD pure differentiated-type, MD mixed differentiated-type, SD standard deviation, ESD endoscopic submucosal dissection, LNM lymph node metastasis